Special Issue "Cancers: Genetics and Cellular Perspective"
Deadline for manuscript submissions: closed (29 June 2023) | Viewed by 17573
2. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain
Interests: identification of new genes involved in cancer, its characterization and traslation to clinic; the identification and validation of new targets for anticancer drug
Special Issues, Collections and Topics in MDPI journals
Interests: pai-1/serpin e-1; rectal cancer; chemoresistance; therapy; Pim kinases; ovarian cancer; cancer stem cells; therapy resistance; Bladder; Ureteral Urothelial Hyperplasia
2. Departamento de Bioquímica Vegetal y Biología Molecular, Universidad de Sevilla, Facultad de Biología, Avda. de la Reina Mercedes 6, 41012 Seville, Spain
3. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain
Interests: biochemical molecular biology
In recent years, we have been witnessing unprecedented technological developments in genetics and molecular as well as cellular biology. Methodologies such as CRISPR-Cas9, genomics, transcriptomics, metabolomics, single-cell technologies, super-resolution imaging, organoid cultures, or genome-wide association studies are undoubtedly contributing to remarkable advances in our knowledge on cancer genetics and cell biology. Studies about the interaction of cancer cells with the tumor microenvironment, clonal selection during tumor evolution, genomic instability and mutations, or genome-wide association, among others, are providing new clues to find therapeutic approaches based on personalized medicine.
In this Special Issue, we welcome original research articles and reviews focusing on genetic as well as cellular approaches, providing insights into different aspects of cancer genetics and cellular biology, including, but not limited to, the molecular bases of carcinogenesis, chromosomal instability, mutation rates, the tumor microenvironment, genetic heterogeneity, or therapy resistance. We hope that your contributions will advance this exciting multidisciplinary field.
Dr. Amancio Carnero
Dr. Sandra Muñoz-Galván
Dr. José M. García-Heredia
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- mutation rates
- genomic instability
- hereditary cancer syndrome
- genetic heterogeneity
- clonal selection
- genome-wide association studies
- tumor microenvironment